Covid-19: Merck's pill accused of accelerating virus mutations

Released on the market in 2021, it was the first anti-Covid pill, a notable advance for a pharmaceutical arsenal that until now consisted only of vaccines and treatments that required complex intravenous administration.

Mai mulţi cercetători afirmă că acest tratament contribuie la apariţia unor mutaţii ale noului coronavirus, iar în teorie, acest lucru ar putea duce la apariţia unor variante periculoase, informează AFP, potrivit Agerpres.„Tratamentul cu Molnupiravir a lăsat o urmă vizibilă în bazele de date mondiale de secvenţiere a genomului virusului”, au concluzionat autorii unui studiu publicat luni în revista Nature.Molnupiravir este un tratament dezvoltat…

The use of the anti-COVID-19 pill developed by Merck could lead to the worsening of the pandemic. The Molnupiravir pill is thought to contribute to the emergence of mutations of the new coronavirus, with a risk that remains theoretical for now: the appearance of dangerous variants.

However, it had been recommended by the World Health Organization (WHO). Two years after its launch on the market, is the Merck anti-COVID pill now likely to worsen the pandemic? Researchers say that this treatment helps to

According to a study published in the journal Nature, this anti-Covid treatment contributes to the emergence of virus mutations that can give rise to dangerous variants: Merck's anti-COVID pill